Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17 by Brulé, S.Y, Jonker, D.J, Karapetis, C.S, O’Callaghan, C.J, Moore, M.J, Wong, R, Tebbutt, N.C, Underhill, Cr, Yip, D, Zalcberg, J.R, Tu, D, Goodwin, R.A

Get full text

The Role of Biological Agents in the Resection of Colorectal Liver Metastases by Nordlinger, B, Adam, R, Arnold, D, Zalcberg, J.R, Gruenberger, T

Get full text

[780] NOVEL HEPARANASE INHIBITOR PI-88 EXTENDS DISEASE FREE SURVIVAL IN A RANDOMIZED PHASE II ADJUVANT CLINICAL TRIAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) AFTER CURATIVE... by Chen, P.J, Lee, PH, Lin, D.Y, Wu, C.C, Jeng, L.B, Lin, P.W, Mok, K.T, Gautam, A.M, Zalcberg, J.R

Get full text

PGI15 - HEALTHCARE RESOURCE UTILIZATION (HCRU) IN METASTATIC OR UNRESECTABLE GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER PATIENTS RECEIVING SECOND-LINE TREATMENT by Gomez-Ulloa, D., Amonkar, M., Kothari, S., Cheung, W.Y., Chau, I., Zalcberg, J.R., Nuria, L., Falcone, A.

Get full text

7P Molecular targeted therapies based on metastatic site in first-line treatment for colorectal cancer patients: An ARCAD pooled analysis by Raeisi, M., Cohen, R., Chibaudel, B., Hurwitz, H., Saltz, L., Kabbinavar, F., Tebbutt, N., Maughan, T., Douillard, J-Y., Van Cutsem, E., Bokemeyer, C., Adams, R.A., Zalcberg, J.R., Yoshino, T., Cremolini, C., Shi, Q., André, T., De Gramont, A.

Get full text

62P Updated overall survival and safety with ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib and harboring KIT exo... by Blay, J-Y., Jones, R.L., Gelderblom, H., George, S., Schöffski, P., von Mehren, M., Zalcberg, J.R., Kang, Y-K., Razak, A.R. Abdul, Trent, J.C., Attia, S., Le Cesne, A., Davis, E., Sprott, K., Cox, P., Sherman, M.L., Ruiz-Soto, R., Heinrich, M., Bauer, S.

Get full text

3520 POSTER Worldwide differences in the surgical management of gastric cancer: results of the REGATE study by Ter-Ovanesov, M, Bang, Y, Wu, C, Yalcin, S, Roth, A, Zalcberg, J.R, Soloviev, V.I, Oliveros, R, Yankin, A.V, Narvaez, C.J

Get full text

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia by Cunningham, D., Zalcberg, J.R., Rath, U., Olver, I., Van Cutsem, E., Svensson, C., Scitz, J.F., Harper, P., Kerr, D., Perez-Manga, G., Azab, M., Seymour, L., Lowery, K.

Get full text

Hypoxemia due to right-to-left shunt in the carcinoid syndrome; beneficial response to octreotide by Hart, D, Zalcberg, J. R.

Get full text

‘Tomudex’ (ZD1694): Results of a Randomised Trial in Advanced Colorectal Cancer Demonstrate Efficacy and Reduced Mucositis and Leucopenia by Cunningham, D., Zalcberg, J.R., Rath, U., Olver, I., Cutsem, E. Van, Svensson, C., Seitz, J.F., Harper, P., Kerr, D., Perez-Manga, G., Azab, M., Seymour, L., Lowery, K.

Get full text

1084 Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC) by Zalcberg, J.R., Bishop, J.F., Millward, M.J., Zimet, A., Laird, J., Barter, C., Seward, D., McKeage, M.J., Friedlander, M.L., Toner, G., Berille, J., Blanc, C.

Get full text